These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 12693859

  • 1. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F, Mucha V, Slováková R, Varecková E.
    Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
    [Abstract] [Full Text] [Related]

  • 2. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T, Sládková T, Gocník M, Mucha V, Varecková E, Kostolanský F.
    Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
    [Abstract] [Full Text] [Related]

  • 3. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y.
    Vaccine; 2004 Jun 02; 22(17-18):2244-7. PubMed ID: 15149783
    [Abstract] [Full Text] [Related]

  • 4. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection.
    Gocník M, Fislová T, Mucha V, Sládková T, Russ G, Kostolanský F, Varečková E.
    J Gen Virol; 2008 Apr 02; 89(Pt 4):958-967. PubMed ID: 18343837
    [Abstract] [Full Text] [Related]

  • 5. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.
    Staneková Z, Adkins I, Kosová M, Janulíková J, Sebo P, Varečková E.
    Antiviral Res; 2013 Jan 02; 97(1):24-35. PubMed ID: 23036818
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
    Tang M, Harp JA, Wesley RD.
    Arch Virol; 2002 Nov 02; 147(11):2125-41. PubMed ID: 12417948
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.
    Arch Virol; 2006 May 02; 151(5):921-31. PubMed ID: 16292596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S, Yoshii H, Akagi T, Akashi M, Ishikawa T, Okuno Y, Takahashi M, Yamanishi K, Mori Y.
    Vaccine; 2007 Nov 28; 25(49):8270-8. PubMed ID: 17977633
    [Abstract] [Full Text] [Related]

  • 15. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T, Watanabe I, Ito S, Fujii H, Moriyama M, Tamura S, Takahashi H, Sawa H, Chiba J, Kurata T, Sata T, Hasegawa H.
    J Virol; 2005 Mar 28; 79(5):2910-9. PubMed ID: 15709010
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL.
    Vaccine; 2006 Mar 10; 24(11):1966-74. PubMed ID: 16343703
    [Abstract] [Full Text] [Related]

  • 20. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
    Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF.
    J Infect Dis; 2007 Jun 01; 195(11):1598-606. PubMed ID: 17471429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.